Re:Trials avoid high risk patients and underestimate drug harms
by jghn on Tuesday December 09, 2025 @10:29AM
(#46205970)
This also comes up with rankings of cancer centers. As the rankings get based on metrics that include things like survival, taking on the hard patients can have a negative impact on their rank. I've seen this cause internal debates on how to handle.
[ Parent
| on HN ]
Re:Trials avoid high risk patients and underestimate drug harms
by ryanmcbride on Tuesday December 09, 2025 @11:00AM
(#46206432)
It's nowhere near my industry and I know virtually nothing about what really goes into these sorts of things, but seems like maybe whichever organization is doing the rankings should simply make that a negative metric. Like, a super negative metric.